Invus Public Equities, L.P.
Insider CIK 1340097 · LXRX Director, 10% owner · GLYC 10% owner · SQZ 10% owner · SEER 10% owner · SRRK 10% owner · GBIO 10% owner · OMGA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding Corp | S Sale | 2024-12-10 | 2024-12-12 | 1,600,000 | $41.65 | $66.64M | 9,250,005 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-11-25 | 2024-11-27 | 30,683 | $40.14 | $1.23M | 10,850,154 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-11-25 | 2024-11-27 | 149 | $40.98 | $6.1K | 10,850,005 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-11-25 | 2024-11-27 | 126,442 | $39.51 | $5.00M | 10,880,837 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-11-25 | 2024-11-27 | 43,887 | $38.43 | $1.69M | 11,007,279 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-11-25 | 2024-11-27 | 208,272 | $37.63 | $7.84M | 11,051,166 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-08-08 | 2024-08-09 | 260,873 | $0.19 | $49.6K | 6,317,565 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-08-07 | 2024-08-09 | 61,488 | $0.18 | $11.1K | 6,578,438 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-08-06 | 2024-08-07 | 55,732 | $0.18 | $10.0K | 6,639,926 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-08-05 | 2024-08-07 | 164,523 | $0.19 | $31.3K | 6,695,658 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-08-02 | 2024-08-05 | 286,200 | $0.20 | $57.2K | 6,860,181 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-08-01 | 2024-08-05 | 63,564 | $0.22 | $14.0K | 7,146,381 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-07-30 | 2024-07-30 | 756,835 | $0.22 | $166.5K | 7,209,945 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-07-29 | 2024-07-30 | 363,949 | $0.24 | $87.3K | 7,966,780 | SEC↗ |
| GLYC GLYCOMIMETICS INC | S Sale | 2024-07-26 | 2024-07-30 | 258,335 | $0.24 | $62.0K | 8,330,729 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-05-10 | 2024-05-14 | 1,150,922 | $108.50 | $124.88M | 1,150,922 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-05-10 | 2024-05-14 | 1,150,922 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-05-10 | 2024-05-14 | 57,546,100 | — | $0 | 136,180,481 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2024-03-13 | 2024-03-13 | 1,150,922 | $108.50 | $124.88M | 1,150,922 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-10-12 | 2023-10-16 | 10,150 | $8.55 | $86.8K | 11,259,438 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-10-12 | 2023-10-16 | 2,189,781 | $6.85 | $15.00M | 11,249,288 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-05 | 2023-06-05 | 27,775,050 | $2.60 | $72.22M | 78,634,381 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-04-28 | 2023-05-02 | 31,557 | $6.43 | $202.9K | 9,059,507 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-24 | 2023-02-28 | 100,000 | $1.70 | $170.0K | 8,589,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-23 | 2023-02-23 | 200,000 | $1.75 | $350.0K | 8,489,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-22 | 2023-02-23 | 150,000 | $1.79 | $268.5K | 8,289,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-21 | 2023-02-23 | 50,000 | $1.85 | $92.5K | 8,139,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-17 | 2023-02-17 | 200,000 | $1.71 | $342.0K | 8,089,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-16 | 2023-02-17 | 315,266 | $1.68 | $529.6K | 7,889,064 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-15 | 2023-02-17 | 1,000,000 | $2.16 | $2.16M | 7,573,798 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2023-02-09 | 2023-02-13 | 11,451 | $3.24 | $37.1K | 6,573,798 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2023-01-09 | 2023-01-11 | 1,094 | $9.48 | $10.4K | 9,027,950 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-01-05 | 2023-01-09 | 48,774 | $9.33 | $455.1K | 9,029,044 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2022-10-25 | 2022-10-27 | 130,265 | $8.04 | $1.05M | 8,980,270 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2022-10-04 | 2022-10-07 | 66,000 | $7.89 | $520.7K | 8,850,005 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2022-10-03 | 2022-10-07 | 33,971 | $7.03 | $238.8K | 8,784,005 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2022-08-05 | 2022-08-09 | 2,426,070 | $2.50 | $6.07M | 50,859,331 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2022-08-01 | 2022-08-01 | 16,173,800 | $2.50 | $40.43M | 48,433,261 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-03 | 5,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-03 | 1,323,530 | — | $0 | 1,398,530 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-03 | 875,000 | $17.00 | $14.88M | 2,273,530 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-07-30 | 2021-08-03 | 75,000 | $16.14 | $1.21M | 75,000 | SEC↗ |
| SEER Seer, Inc. | S Sale | 2021-02-01 | 2021-02-03 | 252,545 | $64.15 | $16.20M | 5,588,366 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2020-12-16 | 2020-12-17 | 10,937,500 | $3.20 | $35.00M | 32,259,461 | SEC↗ |
| SEER Seer, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 474,478 | — | $0 | 0 | SEC↗ |
| SEER Seer, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 373,831 | — | $0 | 0 | SEC↗ |
| SEER Seer, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 3,953,381 | — | $0 | 0 | SEC↗ |
| SEER Seer, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 249,221 | — | $0 | 0 | SEC↗ |
| SEER Seer, Inc. | P Buy | 2020-12-08 | 2020-12-10 | 790,000 | $19.00 | $15.01M | 5,840,911 | SEC↗ |
| SEER Seer, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 5,050,911 | — | $0 | 5,050,911 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 843,490 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 240,375 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion | 2020-11-03 | 2020-11-03 | 1,141,308 | — | $0 | 1,141,308 | SEC↗ |
| SQZ SQZ Biotechnologies Co | P Buy | 2020-11-03 | 2020-11-03 | 465,000 | $16.00 | $7.44M | 1,606,308 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 2,186,820 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 1,073,076 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2020-06-16 | 2020-06-18 | 800,000 | $19.00 | $15.20M | 2,814,191 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-18 | 2,014,191 | — | $0 | 2,014,191 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-28 | 2018-06-29 | 57,724 | $12.45 | $718.7K | 3,516,214 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-27 | 2018-06-29 | 125,114 | $12.54 | $1.57M | 3,458,490 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-25 | 2018-06-26 | 228,264 | $12.95 | $2.96M | 3,333,376 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-22 | 2018-06-26 | 25,461 | $13.36 | $340.2K | 3,105,112 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-21 | 2018-06-21 | 51,600 | $13.27 | $684.7K | 3,079,651 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-20 | 2018-06-21 | 12,391 | $13.28 | $164.6K | 3,028,051 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-19 | 2018-06-21 | 8,982 | $13.45 | $120.8K | 3,015,660 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-18 | 2018-06-18 | 36,584 | $13.06 | $477.8K | 3,006,678 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-14 | 2018-06-18 | 9,200 | $12.66 | $116.5K | 2,970,094 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-12 | 2018-06-12 | 107,023 | $12.83 | $1.37M | 2,960,894 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-11 | 2018-06-12 | 98,626 | $12.75 | $1.26M | 2,853,871 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-08 | 2018-06-12 | 29,747 | $12.89 | $383.4K | 2,755,245 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-07 | 2018-06-07 | 57,439 | $12.93 | $742.7K | 2,725,498 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-06 | 2018-06-07 | 95,079 | $12.58 | $1.20M | 2,668,059 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-05 | 2018-06-07 | 173,121 | $12.45 | $2.16M | 2,572,980 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-04 | 2018-06-04 | 121,803 | $12.24 | $1.49M | 2,399,859 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-06-01 | 2018-06-04 | 147,339 | $12.22 | $1.80M | 2,278,056 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-05-31 | 2018-06-04 | 147,339 | $11.62 | $1.71M | 2,130,717 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-05-30 | 2018-05-30 | 147,339 | $10.32 | $1.52M | 1,983,378 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion deriv | 2018-05-29 | 2018-05-31 | 5,555,556 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-05-29 | 2018-05-30 | 147,339 | $9.84 | $1.45M | 1,836,039 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2018-05-29 | 2018-05-31 | 450,000 | $14.00 | $6.30M | 450,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | C Conversion | 2018-05-29 | 2018-05-31 | 1,946,040 | — | $0 | 1,946,040 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2018-05-25 | 2018-05-30 | 138,700 | $9.62 | $1.33M | 1,688,700 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-11-17 | 2017-11-17 | 50,000 | $9.85 | $492.5K | 1,550,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-11-15 | 2017-11-17 | 130,727 | $10.21 | $1.33M | 1,500,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-11-14 | 2017-11-14 | 215,133 | $9.47 | $2.04M | 1,369,273 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-11-13 | 2017-11-14 | 215,133 | $9.75 | $2.10M | 1,154,140 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-11-10 | 2017-11-14 | 145,680 | $9.74 | $1.42M | 939,007 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2014-11-26 | 2014-11-26 | 149,253,731 | $1.01 | $150.75M | 149,253,731 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2012-10-23 | 2012-10-25 | 3,000,000 | $2.25 | $6.75M | 283,154,744 | SEC↗ |